The Patent Finder

Coulter Pharmaceutical, Inc.

Also on record
Records under this name other than patents Coulter Pharmaceutical, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Coulter Pharmaceutical, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,816,317Tripeptide prodrug compounds
Formerly held
Lapsed on the fee record
Ended Oct 19, 2022 · USPTO record
Lapsed on the fee recordEnded Oct 19, 2022USPTO record
US 7,214,663Tripeptide prodrug compounds
Formerly held
Term ended
Term ended Sep 4, 2022 · USPTO record
Term endedTerm ended Sep 4, 2022USPTO record
US 7,668,662Patient-Specific Dosimetry
Formerly held
Term ended
Term ended Apr 12, 2022 · Medium confidence
Term endedTerm ended Apr 12, 2022Medium confidence
US 7,696,313Prodrug compounds with isoleucine
Formerly held
Term ended
Term ended Jun 11, 2021 · USPTO record
Term endedTerm ended Jun 11, 2021USPTO record
US 8,034,787Enzyme-cleavable prodrug compounds
Formerly held
Term ended
Term ended Jun 10, 2021 · USPTO record
Term endedTerm ended Jun 10, 2021USPTO record
US 7,425,541Enzyme-cleavable prodrug compounds
Formerly held
Lapsed on the fee record
Ended Sep 16, 2020 · USPTO record
Lapsed on the fee recordEnded Sep 16, 2020USPTO record
US 6,287,537Radioimmunotherapy of lymphoma using anti-CD20 antibodies
Formerly held
Term ended
Term ended May 29, 2018 · USPTO record
Term endedTerm ended May 29, 2018USPTO record
US 6,090,365Radioimmunotherapy of lymphoma using anti-CD20 antibodies
Formerly held
Term ended
Term ended Nov 18, 2017 · USPTO record
Term endedTerm ended Nov 18, 2017USPTO record
US 6,338,835Radioprotectant for peptides labeled with radioisotope
Formerly held
Term ended
Ended no later than Aug 21, 2017 · USPTO record
Term endedEnded no later than Aug 21, 2017USPTO record
US 6,015,542Radioimmunotherapy of lymphoma using anti-CD20 antibodies
Formerly held
Term ended
Term ended Sep 10, 2016 · USPTO record
Term endedTerm ended Sep 10, 2016USPTO record
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited